GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Intrinsic Value: Projected FCF

Daito Pharmaceutical Co (TSE:4577) Intrinsic Value: Projected FCF : 円2,856.38 (As of Dec. 14, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-12-14), Daito Pharmaceutical Co's Intrinsic Value: Projected FCF is 円2,856.38. The stock price of Daito Pharmaceutical Co is 円2058.00. Therefore, Daito Pharmaceutical Co's Price-to-Intrinsic-Value-Projected-FCF of today is 0.7.

The historical rank and industry rank for Daito Pharmaceutical Co's Intrinsic Value: Projected FCF or its related term are showing as below:

TSE:4577' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.69   Med: 1.29   Max: 2.37
Current: 0.72

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Daito Pharmaceutical Co was 2.37. The lowest was 0.69. And the median was 1.29.

TSE:4577's Price-to-Projected-FCF is ranked better than
85.71% of 609 companies
in the Drug Manufacturers industry
Industry Median: 1.77 vs TSE:4577: 0.72

Daito Pharmaceutical Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Daito Pharmaceutical Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Intrinsic Value: Projected FCF Chart

Daito Pharmaceutical Co Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,742.47 2,719.98 3,006.61 3,033.05 2,856.38

Daito Pharmaceutical Co Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 2,856.38 -

Competitive Comparison of Daito Pharmaceutical Co's Intrinsic Value: Projected FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daito Pharmaceutical Co's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's Price-to-Projected-FCF falls into.



Daito Pharmaceutical Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Daito Pharmaceutical Co's Free Cash Flow(6 year avg) = 円332.14.

Daito Pharmaceutical Co's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (May24)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*332.144+52068*0.8)/15.690
=2,856.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daito Pharmaceutical Co  (TSE:4577) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Daito Pharmaceutical Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=2058.00/2856.3752492346
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daito Pharmaceutical Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Daito Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co Headlines

No Headlines